Neuberger Berman Group’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
10,565
+1,857
| +21% | +$233K | ﹤0.01% | 1256 |
|
|
2025
Q1 | $963K | Sell |
8,708
-159,468
| -95% | -$17.6M | ﹤0.01% | 1324 |
|
|
2024
Q4 | $23M | Buy |
168,176
+8,633
| +5% | +$1.18M | 0.02% | 623 |
|
|
2024
Q3 | $18.4M | Buy |
159,543
+35,802
| +29% | +$4.13M | 0.01% | 678 |
|
|
2024
Q2 | $17M | Buy |
123,741
+6,709
| +6% | +$924K | 0.01% | 669 |
|
|
2024
Q1 | $16.1M | Buy |
117,032
+3,275
| +3% | +$452K | 0.01% | 696 |
|
|
2023
Q4 | $15M | Buy |
113,757
+3,012
| +3% | +$397K | 0.01% | 687 |
|
|
2023
Q3 | $12.5M | Buy |
110,745
+355
| +0.3% | +$39.9K | 0.01% | 703 |
|
|
2023
Q2 | $10.4M | Buy |
110,390
+103,961
| +1,617% | +$9.8M | 0.01% | 739 |
|
|
2023
Q1 | $651K | Sell |
6,429
-33
| -0.5% | -$3.34K | ﹤0.01% | 1377 |
|
|
2022
Q4 | $772K | Sell |
6,462
-86
| -1% | -$10.3K | ﹤0.01% | 1315 |
|
|
2022
Q3 | $696K | Sell |
6,548
-1,141
| -15% | -$121K | ﹤0.01% | 1364 |
|
|
2022
Q2 | $750K | Buy |
7,689
+207
| +3% | +$20.2K | ﹤0.01% | 1364 |
|
|
2022
Q1 | $702K | Buy |
7,482
+2,948
| +65% | +$277K | ﹤0.01% | 1445 |
|
|
2021
Q4 | $379K | Buy |
4,534
+1,365
| +43% | +$114K | ﹤0.01% | 1628 |
|
|
2021
Q3 | $301K | Buy |
3,169
+28
| +0.9% | +$2.66K | ﹤0.01% | 1598 |
|
|
2021
Q2 | $305K | Buy |
3,141
+191
| +6% | +$18.5K | ﹤0.01% | 1602 |
|
|
2021
Q1 | $287K | Sell |
2,950
-330
| -10% | -$32.1K | ﹤0.01% | 1613 |
|
|
2020
Q4 | $315K | Buy |
3,280
+19
| +0.6% | +$1.83K | ﹤0.01% | 1495 |
|
|
2020
Q3 | $314K | Buy |
3,261
+330
| +11% | +$31.8K | ﹤0.01% | 1436 |
|
|
2020
Q2 | $358K | Sell |
2,931
-51,832
| -95% | -$6.33M | ﹤0.01% | 1335 |
|
|
2020
Q1 | $4.74M | Sell |
54,763
-5,827
| -10% | -$504K | 0.01% | 796 |
|
|
2019
Q4 | $6.51M | Sell |
60,590
-2,135
| -3% | -$229K | 0.01% | 814 |
|
|
2019
Q3 | $5.65M | Buy |
+62,725
| New | +$5.65M | 0.01% | 825 |
|
|
2019
Q2 | – | Sell |
-80,284
| Closed | -$7.07M | – | 1569 |
|
|
2019
Q1 | $7.07M | Sell |
80,284
-77,663
| -49% | -$6.84M | 0.01% | 794 |
|
|
2018
Q4 | $11.3M | Sell |
157,947
-126,635
| -44% | -$9.04M | 0.02% | 717 |
|
|
2018
Q3 | $35M | Sell |
284,582
-46,913
| -14% | -$5.77M | 0.04% | 489 |
|
|
2018
Q2 | $32.6M | Sell |
331,495
-29,300
| -8% | -$2.88M | 0.04% | 514 |
|
|
2018
Q1 | $29.9M | Sell |
360,795
-116,000
| -24% | -$9.62M | 0.03% | 532 |
|
|
2017
Q4 | $37M | Buy |
476,795
+21,500
| +5% | +$1.67M | 0.04% | 482 |
|
|
2017
Q3 | $27.9M | Sell |
455,295
-9,309
| -2% | -$570K | 0.03% | 532 |
|
|
2017
Q2 | $21.4M | Buy |
464,604
+33,021
| +8% | +$1.52M | 0.03% | 592 |
|
|
2017
Q1 | $18.7M | Buy |
431,583
+112,500
| +35% | +$4.87M | 0.02% | 615 |
|
|
2016
Q4 | $12.3M | Buy |
319,083
+302,704
| +1,848% | +$11.7M | 0.02% | 705 |
|
|
2016
Q3 | $829K | Buy |
+16,379
| New | +$829K | ﹤0.01% | 1145 |
|
|
2016
Q2 | – | Sell |
-10,352
| Closed | -$409K | – | 1565 |
|
|
2016
Q1 | $409K | Sell |
10,352
-16,135
| -61% | -$637K | ﹤0.01% | 1303 |
|
|
2015
Q4 | $1.5M | Buy |
+26,487
| New | +$1.5M | ﹤0.01% | 1053 |
|